PCNI5 GEMZAR RETROSPECTIVE ECONOMIC ANALYSIS OF CLINICAL TRIALS (GREAT2)- A PATIENT-LEVEL COST COMPARISON OF THREE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN FRANCE
Abstract
Authors
R Launois S Avoinet K Le Lay D Tilden S Bhalla A Kielhorn N Chemali